A Shared Commitment to Find Answers

We still have urgent questions remaining about Tatton Brown Rahman Syndrome (TBRS):

How does TBRS affect different systems of the body?

What clinical guidelines are most effective?

Are there interventions that work better for TBRS?

What pathways can lead us to therapies

At the TBRS Community, we believe that progress starts with partnership. We invite patients, families, and researchers to be part of the discovery process together.

Our Approach to Patient-Centered Research

We prioritize the voices of those living with TBRS. Through our Patient Priorities Survey, we identify what matters most to families and share those priorities with the scientific community. To support these goals, we’ve developed a Research Toolbox with valuable resources for advancing TBRS science.

Download Updated Clinical Information

TBRS Community Research Roadmap

Launched in 2021 in collaboration with the National Organization for Rare Disorders (NORD), our Patient Registry is a secure, global database collecting health and diagnostic information from individuals with TBRS and related DNMT3A conditions.

The registry functions as a natural history study, meaning it tracks symptoms over time to better understand the evolution of TBRS.

What We’ve Learned So Far:

There are over 90 known DNMT3A variants that cause TBRS

Nearly 50% of participants experience seizures

Over 50% report cardiac involvement

We’ve recently expanded the Registry to include all germline DNMT3A variants, including those linked to Heyn-Sproul-Jackson Syndrome (HESJAS) and other phenotypes.

Registry data is linked to our Biorepository samples using the Clinical Research ID (CRID).

View our Research Roadmap

TBRS Biorepository

We have collected over 50 patient and control samples, which can be linked to patient registry data, creating a powerful data set to accelerate TBRS research. All samples are linked to corresponding Patient Registry data using the CRID system. Available samples include:

Mouse Models

Several DNMT3A / TBRS mouse models are available for research use. Below are currently available models, related publications, and contact details:

DNMT3A exon deletion

Dr. Margaret A. Goodell – Baylor College of Medicine

goodell@bcm.edu

P904L (P900L in mouse)

R882H (R878H in mouse)

Dr. Timothy J. Ley – Washington University

timley@wustl.edu

Also available via Jackson Labs:

W297del (W293del in mouse)

Dr. Margaret A. Goodell – Baylor College of Medicine

goodell@bcm.edu

DNMT3A1 knockout

Dr. Margaret A. Goodell – Baylor College of Medicine

goodell@bcm.edu

iPSC Lines

We currently offer one iPSC line, created using a patient sample from our Biorepository:

Additional lines are in development and will be published here when available.

Research Roundtables

We host Research Roundtables to bring families and scientists together in co-designing studies.